These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 27440178

  • 1. Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.
    Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Hidaka T, Haga T, Hashimoto A, Morimoto R, Aiba S.
    J Dermatol; 2017 Mar; 44(3):e13-e14. PubMed ID: 27440178
    [No Abstract] [Full Text] [Related]

  • 2. Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab.
    Kitano S, Tatsuno K, Ishibe J, Shimauchi T, Fujiyama T, Ito T, Ogawa N, Tokura Y.
    Acta Derm Venereol; 2018 Jul 11; 98(7):704-705. PubMed ID: 29405244
    [No Abstract] [Full Text] [Related]

  • 3. Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy.
    Narahira A, Yanagi T, Cho KY, Nakamura A, Miyoshi H, Hata H, Imafuku K, Kitamura S, Shimizu H.
    J Dermatol; 2017 Apr 11; 44(4):e70. PubMed ID: 27608187
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.
    Pierrard J, Petit B, Lejeune S, Seront E.
    BMJ Case Rep; 2019 Aug 21; 12(8):. PubMed ID: 31439558
    [Abstract] [Full Text] [Related]

  • 8. Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer.
    Takaya K, Sonoda M, Fuchigami A, Hiyoshi T.
    Intern Med; 2017 Sep 15; 56(18):2463-2469. PubMed ID: 28824067
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment [Letter to the Editor].
    Cho KY, Miyoshi H, Nakamura A, Kurita T, Atsumi T.
    Endocr J; 2017 Feb 27; 64(2):235-236. PubMed ID: 28070057
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.
    Takimoto R, Otsuka A, Kaku Y, Honda T, Kabashima K.
    Eur J Dermatol; 2018 Feb 01; 28(1):84-85. PubMed ID: 29400292
    [No Abstract] [Full Text] [Related]

  • 17. Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.
    Kuwatsuka Y, Iwanaga A, Kuwatsuka S, Okubo Y, Murayama N, Ishii N, Hashimoto T, Utani A.
    J Dermatol; 2018 Jan 01; 45(1):e21-e22. PubMed ID: 28944534
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A Case of Thyroid Dysfunction and Isolated Adrenocorticotropin Deficiency after Nivolumab Therapy for Malignant Melanoma].
    Nishio K, Okada Y, Kurozumi A, Tanaka Y.
    J UOEH; 2021 Jan 01; 43(1):97-102. PubMed ID: 33678791
    [Abstract] [Full Text] [Related]

  • 20. Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.
    Page B, Borradori L, Beltraminelli H, Yawalkar N, Hunger RE.
    J Eur Acad Dermatol Venereol; 2018 Jul 01; 32(7):e256-e257. PubMed ID: 28430376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.